Epidemiology observational study of the onset frequency of hypergastrinemia in the acid-secreting suppressant administration treatment of patients with gastroesophageal reflux disease

Epidemiology observational study of the onset frequency of hypergastrinemia in the acid-secreting suppressant administration treatment of patients with gastroesophageal reflux disease - Epidemiologic studies of the frequency of hypergastrinemia in the GERD treatment

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030312

Enrollment

1000

Registered

2017-12-08

Start date

2017-12-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The GERD patients under treatment with the acid-secreting suppressant

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with gastroesophageal reflux disease under treatment by the administration of acid-secreting suppressant

Exclusion criteria

Exclusion criteria: non

Design outcomes

Primary

Measure	Time frame
It is frequency of hypergastrinemia after eight weeks after the start of therapy of the acid-secreting suppressant	—

Secondary

Measure	Time frame
Association of duration of treatment and hypergastrinemia in the acid-secreting suppressant	—

Countries

Japan

Contacts

Public ContactFunaki Yasuchi

Department of Internal Medicine Aichi Medical University Division Gastroenterology

momomaru@aichi-med-u.ac.jp0561-62-3311

Outcome results